DriverMONI:マルチモーダル深層学習によるがんドライバー遺伝子予測 - マルチオミクスデータと条件特異的ネットワーク情報の統合
Abstract:
In the past few decades, several methods, ranging from statistical algorithms to deep learning models, have been proposed for driver gene identification. Although recent graph neural network-based methods have achieved progress using biological networks, the static and incomplete nature of networks can compromise the predictive power of the models. Here, we introduce a multimodal approach for driver gene prediction called DriverMONI that leverages pairs of complementary information from multiomics data and biological networks. In particular, DriverMONI utilizes condition-specific subnetworks of protein-protein interaction for generating input graphs and node attributes for graph attention network, which makes the model condition-specific and improves prediction accuracy. Weempirically show the importance of multimodality and the ability of DriverMONI to mitigate the incompleteness of protein-protein interaction networks. In addition, comparative analysis showed that DriverMONI achieved the best performance among competing methods including graph neural network-based models using The Cancer Genome Atlas data, while having a strong consensus with other methods. The source code of DriverMONI is available at https://github.com/BML-cbnu/DriverMONI.
さらに関連する動画
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
関連する概念動画
Cancer Survival Analysis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
